Healthcare Reform Passes House, Has Implications for Pharma, CME

The healthcare reform bill that passed the House on March 21 with a 219-212 majority aims to change not only healthcare delivery in the United States, but also the reporting requirements for payments between pharmaceutical and medical-device companies and physicians. Included in the healthcare reform bill, called the Patient Protection and Affordable Care Act, are Physician Payment Sunshine Provisions that would affect both

Register to view the full article

Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish